ChemAnalyst

According to ChemAnalyst, The Norfloxacin Prices experienced a notable upward trend during the first quarter of 2026, supported by rising feedstock costs, increasing pharmaceutical manufacturing activity, and resilient demand for antibiotic active pharmaceutical ingredients (APIs). Across key global markets including North America, Asia-Pacific, and Europe, pricing remained firm as manufacturers faced higher production expenses while downstream pharmaceutical demand continued

According to ChemAnalyst, The Norfloxacin Prices witnessed a notable upward trajectory during the first quarter of 2026, supported by increasing production costs, higher feedstock prices, and resilient pharmaceutical demand across major global markets. North America, Asia-Pacific (APAC), and Europe all recorded quarter-over-quarter price gains, although the underlying market drivers differed by region. Norfloxacin, a broad-spectrum fluoroquinolone antibiotic widely used in ph

The global Norfloxacin Prices market witnessed mixed momentum during Q4 2025, shaped by regional production costs, pharmaceutical demand, raw material pricing, and macroeconomic conditions. Norfloxacin, a widely used fluoroquinolone antibiotic, remains an important active pharmaceutical ingredient (API) across the healthcare and pharmaceutical industries. Its pricing is heavily influenced by manufacturing expenses, supply chain conditions, regulatory developments, and antibio